drugset / Trial / NCT05988177
Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to investigate the efficacy and safety of Carrimycin tablets in hemophagocytic lymphohistiocytosis patients with Carbapenem-resistant infections.
Timeline
- Start
- 2023-08-30
- Primary completion
- 2026-08-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carrimycin | Unknown | 400 mg | Oral |